Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05682170
Title Study of the ZN-d5 and ZN-c3 in Subjects With Acute Myeloid Leukemia (AML)
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors K-Group Alpha, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Alabama at Birmingham Birmingham Alabama 35233 United States Details
University of California San Francisco San Francisco California 94110 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
University of Minnesota Minneapolis Minnesota 53792 United States Details
Albert Einstein College of Medicine - Montefiore Medical Center Bronx New York 10467 United States Details
NYU Langone Health New York New York 10016 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
University of North Carolina at Chapel Hill Chapel Hill North Carolina 27514 United States Details
James Cancer Hospital and Solove Research Institute Columbus Ohio 43210 United States Details
Oregon Health and Science University Portland Oregon 97239 United States Details
Tristar Bone Marrow Transplant Nashville Tennessee 37203 United States Details
University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
The Medical College of Wisconsin Milwaukee Wisconsin 53226 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field